Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05467007 · ClinicalTrials.gov registry record · NA
Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway
A NA study, sponsored by Andrew Meltzer.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT05467007: Completed NA study, sponsored by Andrew Meltzer.
NCT05467007 is a NA study that has completed, run by Andrew Meltzer. The registered enrollment target is 360 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05467007, a NA study, has completed, sponsored by Andrew Meltzer.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
Rapid diagnosis and precise treatment have become possible with multiplex polymerase chain reaction (PCR) panels that can identify a variety of causative agents of acute respiratory illnesses such as bacterial and viral infections in one urgent care visit. While real-time PCR is currently used as a standard for diagnosing acute respiratory illnesses such as influenza due to its high sensitivity and specificity, it typically takes several hours for results which is unfavorable in the urgent care setting. Highly sensitive and rapid random-access PCR tests provide the sensitivity and specificity needed to both rapidly and accurately diagnose acute respiratory illnesses. Similar PCR panels have been used in previous research for the diagnosis of gastrointestinal illnesses in the emergency department and point-of-care testing for hospitalized adults presenting with acute respiratory illness. In this study, the investigators aim to determine if a rapid multiplex PCR test for urgent care patients with symptomatic upper respiratory infections can improve patient and provider-reported outcomes. This study utilizes the Biofire® FilmArray Panel (RP2.1-EZ) which in previous studies has been shown to be highly effective in diagnosing acute respiratory illnesses.
Primary Outcome
Based on any results you have received from today's tests, are you satisfied in the time it has taken to communicate the results?
Interventions
- DIAGNOSTIC_TEST BioFire® Respiratory Panel 2.1-EZ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
What the finished NCT05467007 record still lists
NCT05467007 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which BioFire® Respiratory Panel 2.1-EZ is the first listed.
NCT05467007 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05467007 about?
NCT05467007 is a clinical study titled "Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway". Rapid diagnosis and precise treatment have become possible with multiplex polymerase chain reaction (PCR) panels that can identify a variety of causative agents of acute respiratory illnesses such as bacterial and viral infections in one urgent care visit. While real-time PCR is currently used as a ...
What is the current status of trial NCT05467007?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2022-04-04. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05467007?
The interventions under investigation include: BioFire® Respiratory Panel 2.1-EZ (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05467007?
This trial is sponsored by Andrew Meltzer, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05467007's enrollment target sits among peer trials
360 284th of 2000 higher than 1,713 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI